2024 Pap Smear/HPV Market: Global, Regional, China, India

June 2020 | 230 pages | ID: 24C4515C3FC8EN
Venture Planning Group

Abstracts

This new report from LeadingMarketResearch.com presents a detailed analysis of the global Pap Smear/HPV testing market, including test volume and sales forecasts for major geographic regions and countries:

• Asia-Pacific
• China
• Europe
• India
• Japan
• Latin America
• Middle East Africa
• North America
• Rest of World

The report is available by section, and can be customized to specific information needs and budget.

The report also presents the Pap Smear and HPV clinical significance and current laboratory practice; examines market applications of DNA probes, biochips/microarrays, monoclonal antibodies, immunoassays, IT, chromosome analysis, and other technologies; reviews features and operating characteristics of automated analyzers; profiles leading suppliers and recent market entrants developing innovative technologies and products; and identifies alternative market penetration strategies and entry barriers/risks.

Contains 230 pages

Contents

I. INTRODUCTION

II. WORLDWIDE MARKET AND TECHNOLOGY OVERVIEW

A. Clinical Significance and Laboratory Practices
B. Diagnostic Testing Instrumentation Review and Market Needs
C. Current and Emerging Diagnostic Technologies
  1. Monoclonal and Polyclonal Antibodies
  2. Immunoassays
  3. Molecular Diagnostics
  4. Chromosome Analysis
    a. Chronic Myelogenous Leukemia (CML)
    b. Acute Myeloid Leukemia (AML)
    c. Acute Lymphoblastic Leukemia (ALL)
    d. Malignant Lymphomas Lymphoid Malignancies
    e. Chronic Lymphocytic Leukemia (CLL)
    f. Solid Cancers
    g. Chromosomal Translocation and Oncogenes
  5. Artificial Intelligence
  6. Flow Cytometry
  7. Two Dimensional Gel Electrophoresis (2-DGE)
  8. Biosensors
  9. Competing/Complementing Technologies
D. Personal Testing

III. GLOBAL, REGIONAL, COUNTRY MARKET FORECASTS AND SUPPLIERS SHARES

IV. DESIGN CRITERIA FOR DECENTRALIZED TESTING PRODUCTS

V. ALTERNATIVE MARKET PENETRATION STRATEGIES

A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies

VI. POTENTIAL MARKET ENTRY BARRIERS AND RISKS

A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges

VII. COMPETITIVE PROFILES

The report provides strategic assessments of over 30 leading cancer diagnostics market players and start-up companies with innovative technologies and products, including:
  Abbott
  Affymetrix
  Beckman Coulter/Danaher
  Becton Dickinson
  bioMerieux
  Bio-Rad
  Cepheid
  DiaSorin
  Eiken Chemical
  Elitech Group
  Enzo Biochem
  Fujirebio
  Grifols
  Hologic
  Leica Biosystems
  Ortho-Clinical Diagnostics
  PerkinElmer
  Qiagen
  Roche
  Siemens Healthineers
  Takara Bio
  Thermo Fisher
  Wako and others.

List Of Tables

LIST OF TABLES

TABLE 1 PAP SMEAR GLOBAL TEST VOLUME AND DIAGNOSTICS SALES BY REGION
TABLE 2 HPV GLOBAL TEST VOLUME AND DIAGNOSTICS SALES BY REGION
TABLE 3 GLOBAL MAJOR SUPPLIERS OF PAP SMEAR/HPV DIAGNOSTIC PRODUCTS ESTIMATED MARKET SHARES
TABLE 4 CHINA PAP SMEAR TEST VOLUME AND SALES BY LOCATION
TABLE 5 CHINA HPV TEST VOLUME AND SALES BY LOCATION
TABLE 6 CHINA MAJOR SUPPLIERS OF PAP SMEAR/HPV DIAGNOSTIC PRODUCTS ESTIMATED MARKET SHARES
TABLE 7 INDIA PAP SMEAR TEST VOLUME AND SALES BY LOCATION
TABLE 8 INDIA HPV TEST VOLUME AND SALES BY LOCATION
TABLE 9 INDIA MAJOR SUPPLIERS OF PAP SMEAR/HPV DIAGNOSTIC PRODUCTS ESTIMATED MARKET SHARES